CTRI/2021/03/032021
Not yet recruiting
未知
A Phase 2b study to determine the efficacy of probiotics given in peritransplant period among allogenic stem cell transplant recipients in preventing gram negative bacteremia, mortality, graft versus host disease
Christian Medical College Vellore0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Christian Medical College Vellore
- Status
- Not yet recruiting
- Last Updated
- 4 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\) Age \>18 years.
- •2\) Undergoing Allogenic Stem cell transplant in the Department of Haematology, CMC Vellore. 3\) Presence of CRO or ESBL organism in Pre\-transplant Fecal surveillance
Exclusion Criteria
- •1\) Age \<18 years
- •2\) Susceptible organisms in the Pre\-transplant Faecal surveillance.
- •3\) Patients who already have an ongoing bacterial infection at the time of HSCT.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Phase 2
A phase II study to evaluate the effectiveness of S-1 + Cetuximab for patients with advanced/recurrent colon cancer who cannot undergo intensive therapyadvanced/recurrent colon cancer patients with RAS wild-type tumors who cannot undergo intensive therapyJPRN-UMIN000018484HO HOKKAIDO CANCER CENTER Division of Gastroenterology57
Recruiting
Not Applicable
The study evaluate the efficacy of intraoperative radiotherapy those who underwent neoadjuvant chemotherapy for pancreatic cancer.KCT0005113Yonsei University Health System, Gangnam Severance Hospital80
Active, not recruiting
Phase 1
VAC071: A study to assess efficacy of the ChAd63/MVA PvDBP vaccinesPlasmodium vivax malariaMedDRA version: 20.0Level: LLTClassification code 10047665Term: Vivax malaria (benign tertian)System Organ Class: 100000004862Therapeutic area: Diseases [C] - Parasitic Diseases [C03]EUCTR2019-000643-27-GBniversity of Oxford / Clinical Trials and Research Governance19
Completed
Phase 2
A phase II study to investigate the efficacy of neoadjuvant erlotinib in patients with clinical stage I/II non-small cell lung cancer (NSCLC)early stage lung cancernon-small cell lung cancer stage I/II10038666NL-OMON29708Antoni van Leeuwenhoek Ziekenhuis55
Completed
Phase 2
Phase II Clinical Study Evaluating the Efficacy and Safety of Cetuximab Rechallenge in Patients with Wild-Type RAS, Unresectable, Progressive/Recurrent Colorectal Cancer Refractory to Fluoropyrimidines, Oxaliplatin, Irinotecan, Cetuximab and Bevacizumab: The E-Rechallenge TrialColorectal cancerJPRN-UMIN000016439Public Health Research Foundation50